Special Report on Clinical Trials: Delving into decentralization
Pandemic perils accelerate digital adoption in clinical trials
Daily News
Abbott’s Resp-4-Plex test gains EUA
Abbott’s Resp-4-Plex test gains EUA
Abbott receives EUA for PCR assay to detect and differentiate SARS-CoV-2, Flu A, Flu B, and RSV
Akari & USAISR team up for potential trauma therapy
Akari & USAISR team up for potential trauma therapy
Akari Therapeutics enters agreement with US Army Institute of Surgical Research for nomacopan
Uncovering the origins of malignant rhabdoid tumors
Uncovering the origins of malignant rhabdoid tumors
Researchers discover how malignant rhabdoid tumors begin, and identify potential treatments
ABIONYX reports positive results from CER-001
ABIONYX reports positive results from CER-001
ABIONYX achieves positive clinical results with CER-001 in familial lecithin–cholesterol acyltransferase deficiency
FDA approves Pepaxto
FDA approves Pepaxto
Oncopeptides’ Pepaxto has been approved for patients with triple-class refractory multiple myeloma
Thermo Fisher acquires Mesa Biotech
Thermo Fisher acquires Mesa Biotech
Thermo Fisher has completed the acquisition of Mesa Biotech and its Accula System PCR testing platform
